Using the proposed approaches, we succeeded in improving the sliding ability of Cas9 (1,779 residues including MBP) to that of the p53 tetramer, a tumor-suppressing protein with a similar size (1572 residues)40,41. The gene discussed is MBP; the disease is neoplasm.